11,September, 2024 (Day 1)
Main Hall
- Opening Ceremony
- The Hong Kong Polytechnics University Event
- Guangdong Biotechnology Business Networking
- BSP Medical -Accurate heart attack risk warning
Theaters
Theater 1
- Tapping the potential of HK/GBA for clinical trials
- Gateway to Growth: Biotech IPOs on HKEX
- How Cell Therapy is Advancing Healthcare
Theater 2
- Artificial intelligence governance and intellectual property in healthcare
- Navigating the Path to IND Approval: Strategies for Successful FDA Submissions
- Breakthrough Innovations to Redefine Therapeutics
Theater 3
- International perspectives on Hong Kong as a biotech hub of the world
- The time is now: preparing for the next pandemic
Theater 4
- Biotech & biopharma new quality productive forces in Mainland China
- Can biotech be Hong Kong’s next pillar of growth?
- Chinese medicine applications for global health
- 借助[BIOHK香港国际生物科技论坛暨展览]平台共建合作谅解备忘录(MOU)签约仪式
12,September, 2024 (Day two)
Main Hall
- Opening Remarks
- KEYNOTE SESSION: Hong Kong, an ideal ground for life sciences and healthcare industry development
- KEYNOTE SESSION: Strengthen medical and prevention cooperation in the Greater Bay Area to eliminate hepatitis
- KEYNOTE SESSION: The development frontiers and prospects of digital traditional Chinese medicine
- KEYNOTE SESSION: Initiative to reshape the discipline of hepatology in Asian-Pacific region under “One Country, two system”
- KEYNOTE SESSION: In the mood for cell therapy – a better tomorrow has arrived
- The path to Precision Medicine and Digital Medicine (I)
- The path to Precision Medicine and Digital Medicine (II)
Theaters
Theater 1
- Charting a new regulatory pathway in Hong Kong – the CMPR
- HK Government Policies for Biotech Growth
- Hong Kong: The Super Connector for Mainland China and Global Biotech
- Mainland Perspectives on Clinical Trials and CMPR
Theater 2
- RNA Medicine to Address Clinical Needs
- Longevity: East meets West
Theater 3
- Company Pitching
Theater 4
- Black Technology
- New role for Chinese Medicine: Health maintenance
13,September, 2024 (Day Three)
Main Hall
- KEYNOTE SESSION:On the Role and Place of AI in the Era of Geopolitics
- KEYNOTE SESSION: Inheritance and innovation: Bushen Huoxue Fa for the Treatment of Diabetic Nephropathy
- KEYNOTE SESSION:A New Era for Neurodegenerative Disorders: Opportunities and Challenges
Theaters
Theater 1
- Sino-US Biotechnology Investment, Merger & Acquisition Summit Forum (Closed door)
- Primary Healthcare and Digital Health Development Forum
- Biomedical imaging: future applications, policy and business
Theater 2
- Targeting the Brain: Precision Neuro-therapeutics
- Obesity and Diabetes: new drugs and interventions
- Integrating Eastern Wisdom with Western Innovation: Case of Breast Cancer
- Ophthalmology: more than meets the eye
Theater 3
- Bridging Research from Academia to Cancer Entrepreneurship Building Successful Biotech Companies
- City University of Hong Kong HK Tech 300 Start-ups Pitching
- Company Pitching
Theater 4
- Blockchain Meets Longevity: Success Stories in Harnessing Decentralized Science
- Chinese companies navigating overseas: Case studies
- Landscape of smart health- centric city development
- Synthetic Biology is Shaping our Future
14,September, 2024 (Day Four)
Main Hall
- KEYNOTE SESSION:中医兴旺：摆脱故步自封 开拓推陈出新
- KEYNOTE SESSION:科技创新全链条加速，打造生命健康产业新生态
- 《微生物与疫苗》 – 新冠病毒发现者高福院士科普讲座及著作签赠活动
- STEAM Education and Biotechnology
Theaters
Theater 1
- Navigating Careers in Biotech
- Bio Health Partnering Convention 2024
- Bio Health Partnering Convention 2024
Theater 2
- Hong Kong Association of Women Scientists: Opening and First Inauguration Ceremony
- How to publish in top scientific journals
- Integrative East West approaches to diabetes
Theater 3
- Smart Living: digital innovations for healthy living
- AirDoc Technology: Products showcase and sharing
- Zhaoke Ophthalmology: Focus on clinical needs of ophthalmology
Theater 4